A detailed history of Bank Of Montreal transactions in Care Dx, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 584,056 shares of CDNA stock, worth $10.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
584,056
Previous 585,500 0.25%
Holding current value
$10.6 Million
Previous $7.03 Million 11.97%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$7.96 - $12.37 $11,494 - $17,862
-1,444 Reduced 0.25%
584,056 $6.19 Million
Q4 2023

Feb 08, 2024

BUY
$4.9 - $12.86 $1.78 Million - $4.67 Million
362,996 Added 163.14%
585,500 $7.03 Million
Q3 2023

Nov 01, 2023

SELL
$7.0 - $11.26 $450,352 - $724,423
-64,336 Reduced 22.43%
222,504 $1.56 Million
Q2 2023

Aug 02, 2023

BUY
$7.61 - $9.46 $595,779 - $740,613
78,289 Added 37.54%
286,840 $2.44 Million
Q1 2023

Jun 13, 2024

SELL
$8.83 - $17.61 $3.3 Million - $6.58 Million
-373,810 Reduced 64.0%
210,246 $1.92 Million
Q4 2022

Feb 01, 2023

SELL
$10.88 - $20.05 $7,496 - $13,814
-689 Reduced 0.33%
208,551 $2.38 Million
Q3 2022

Nov 10, 2022

SELL
$16.06 - $26.39 $14,453 - $23,751
-900 Reduced 0.43%
209,240 $4.51 Million
Q2 2022

Aug 11, 2022

BUY
$20.49 - $39.72 $362,959 - $703,600
17,714 Added 9.21%
210,140 $5.42 Million
Q1 2022

May 12, 2022

SELL
$28.19 - $46.6 $37,690 - $62,304
-1,337 Reduced 0.69%
192,426 $7.61 Million
Q4 2021

Feb 11, 2022

SELL
$41.2 - $73.6 $2.06 Million - $3.67 Million
-49,908 Reduced 20.48%
193,763 $8.89 Million
Q3 2021

Nov 12, 2021

BUY
$59.15 - $91.99 $1.41 Million - $2.19 Million
23,801 Added 10.83%
243,671 $14.8 Million
Q2 2021

Aug 12, 2021

BUY
$63.02 - $95.11 $13.9 Million - $20.9 Million
219,870 New
219,870 $21.2 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $967M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.